The Economic Impact of Delaying 5-Alpha Reductase Inhibitor Therapy in Men Receiving Treatment for Symptomatic Benign Prostatic Hyperplasia

BACKGROUND: Pharmacologic treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia often includes alpha-blockers and 5-alpha reductase inhibitors. Many clinicians use alpha-blockers for rapid symptom control, later adding 5-alpha reductase inhibitors to modify long-term...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Naslund, Michael, Eaddy, Michael T., Hogue, Susan L., Kruep, Eric J., Shah, Manan B.
Format: Artigo
Jezik:Inglês
Izdano: Engage Healthcare Communications, LLC 2011
Teme:
Business
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4105713/
https://ncbi.nlm.nih.gov/pubmed/25126348
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items